Please use this identifier to cite or link to this item:
http://hdl.handle.net/10884/1454| Title: | CSR: a catalyst for corporate contribution to global health governance? A case study from the pharmaceutical industry |
| Authors: | Monachino, Michelle Moreira, J. Paulo |
| Keywords: | Public health Corporate social responsability Pharmaceutical industry Health promotion |
| Issue Date: | 2016 |
| Publisher: | Hygiea Internationalis: an Interdisciplinary Journal for the History of Public Health |
| Citation: | Monachino, M.; Moreira, J. P. (2016). CSR: a catalyst for corporate contribution to global health governance? A case study from the pharmaceutical industry. Hygiea Internationalis: an Interdisciplinary Journal for the History of Public Health, Vol. 12(2), p. 73-91. |
| Abstract: | Over the past twenty years international health and development agencies (WHO, 1997, 2005; UN, 2002; World Bank, 2002; WEF, 2011) have gradually advocated towards a participation of the private for-profit sector, and especially large multinational corporations (MNCs), in global population health promotion and disease prevention. Participation has been justified in terms of the socioeconomic agency of corporations in a globalized world, as well as connected to the positive and negative social, environmental and health externalities consequent to business manufacturing, distribution and marketing practices. |
| URI: | http://hdl.handle.net/10884/1454 |
| Appears in Collections: | A CE/GS - Artigos |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Corporate social responsability.pdf | 103.42 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.